Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thijo J N Hiltermann"'
Autor:
Stefan Michiels, Leon W.M.M. Terstappen, R Lopez-Lopez, Klaus Pantel, Caroline Dive, Sabine Riethdorf, Elisabetta Rossi, Françoise Farace, Fabiola Fernandez-Gutierrez, Jean-Charles Soria, Fiona H Blackhall, Matthew G Krebs, Thijo J N Hiltermann, Benjamin Besse, Harry J.M. Groen, A Carmel, Lynsey Priest, Andrew G Renehan, Sonja Loges, Paola Gazzaniga, Harriet Wikman, Laura Muinelo-Romay, Colin R Lindsay
Publikováno v:
European Journal of Cancer, 117, 60-68. ELSEVIER SCI LTD
European journal of cancer, 117, 60-68. Elsevier
European Journal of Cancer
European Journal of Cancer, Elsevier, 2019, 117, pp.60-68. ⟨10.1016/j.ejca.2019.04.019⟩
Lindsay, C R, Blackhall, F H, Carmel, A, Fernandez-Gutierrez, F, Gazzaniga, P, Groen, H J M, Hiltermann, T J N, Krebs, M G, Loges, S, López-López, R, Muinelo-Romay, L, Pantel, K, Priest, L, Riethdorf, S, Rossi, E, Terstappen, L, Wikman, H, Soria, J C, Farace, F, Renehan, A, Dive, C, Besse, B & Michiels, S 2019, ' EPAC-lung : pooled analysis of circulating tumour cells in advanced non-small cell lung cancer ' European Journal of Cancer, vol. 117, pp. 60-68 . https://doi.org/10.1016/j.ejca.2019.04.019
Lindsay, C R, Blackhall, F H, Carmel, A, Fernandez-Gutierrez, F, Gazzaniga, P, Groen, H J M, Hiltermann, T J N, Krebs, M G, Loges, S, López-López, R, Muinelo-Romay, L, Pantel, K, Priest, L, Riethdorf, S, Rossi, E, Terstappen, L, Wikman, H, Soria, J C, Farace, F, Renehan, A, Dive, C, Besse, B & Michiels, S 2019, ' EPAC-Lung: Pooled Analysis of Circulating Tumor Cells in Advanced Non-Small Cell Lung Cancer ', European Journal of Cancer, vol. 117, pp. 60-68 . https://doi.org/10.1016/j.ejca.2019.04.019
European journal of cancer, 117, 60-68. Elsevier
European Journal of Cancer
European Journal of Cancer, Elsevier, 2019, 117, pp.60-68. ⟨10.1016/j.ejca.2019.04.019⟩
Lindsay, C R, Blackhall, F H, Carmel, A, Fernandez-Gutierrez, F, Gazzaniga, P, Groen, H J M, Hiltermann, T J N, Krebs, M G, Loges, S, López-López, R, Muinelo-Romay, L, Pantel, K, Priest, L, Riethdorf, S, Rossi, E, Terstappen, L, Wikman, H, Soria, J C, Farace, F, Renehan, A, Dive, C, Besse, B & Michiels, S 2019, ' EPAC-lung : pooled analysis of circulating tumour cells in advanced non-small cell lung cancer ' European Journal of Cancer, vol. 117, pp. 60-68 . https://doi.org/10.1016/j.ejca.2019.04.019
Lindsay, C R, Blackhall, F H, Carmel, A, Fernandez-Gutierrez, F, Gazzaniga, P, Groen, H J M, Hiltermann, T J N, Krebs, M G, Loges, S, López-López, R, Muinelo-Romay, L, Pantel, K, Priest, L, Riethdorf, S, Rossi, E, Terstappen, L, Wikman, H, Soria, J C, Farace, F, Renehan, A, Dive, C, Besse, B & Michiels, S 2019, ' EPAC-Lung: Pooled Analysis of Circulating Tumor Cells in Advanced Non-Small Cell Lung Cancer ', European Journal of Cancer, vol. 117, pp. 60-68 . https://doi.org/10.1016/j.ejca.2019.04.019
Introduction: We assessed the clinical validity of circulating tumour cell (CTC) quantification for prognostication of patients with advanced non-small cell lung cancer (NSCLC) by undertaking a pooled analysis of individual patient data. Methods: Nin
Autor:
Egbert F. Smit, N. C. van Walree, K. Maas, J. Staal-van den Brekel, J. De Langen, Bonne Biesma, M. Youssef-ElSoud, W. Mellema, V. van Noord, Lizza E.L. Hendriks, Sjaak Burgers, A-M.C. Dingemans, S. Ernst, Thijo J N Hiltermann
Publikováno v:
Annals of Oncology. 32:S1327
Autor:
Harry J.M. Groen, A. P. van den Berg, Klaas Kok, A. J. van der Wekken, Thijo J N Hiltermann, Ali Saber
Publikováno v:
Critical Reviews in Oncology/Hematology. 100:107-116
Targeted treatment of advanced non-small cell lung cancer patients with afatinib in EGFR mutation or crizotinib in ALK break positive patients results in profound tumor responses but inevitably induces resistance. In this review we present currently
Autor:
A. J. van der Wekken, Klaas Kok, Thijo J N Hiltermann, Pei Meng, A. P. van den Berg, Anna A. Rybczynska, Ed Schuuring, Wim Timens, Harry J.M. Groen, Jiacong Wei, M. M. Terpstra
Publikováno v:
Annals of Oncology, 30:UNSP mdz413.025. Oxford University Press
Background The detection of driver aberrations such as EGFR and ALK, in tumour tissue or plasma has become important for treating lung cancer patients. The aim of this study is to explore the feasibility of detecting therapy-guiding aberrations in RN
Autor:
Thijo J N Hiltermann, Arja ter Elst, Anneke Miedema, Harry J. Goen, Anthonie J. van der Wekken, Ed Schuuring
Publikováno v:
Cancer Research. 78:1602-1602
Introduction: Immunotherapy shows a durable tumor response in approximately 20% of advanced NSCLC patients. Imaging by CT is used to evaluate tumor response. PD-L1 immunohistochemistry is generally used to predict survival advantages, however with lo
Autor:
Gerald S M A Kerner, Ed Schuuring, Johanna Sietsma, Thijo J N Hiltermann, Remge M Pieterman, Gerard P J de Leede, John W G van Putten, Jeroen Liesker, Tineke E J Renkema, Peter van Hengel, Inge Platteel, Wim Timens, Harry J M Groen, CTMM Air Force Consortium
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70346 (2013)
PLoS ONE
PLoS ONE, 8(7):e70346. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 8(7):e70346. PUBLIC LIBRARY SCIENCE
INTRODUCTION: In randomly assigned studies with EGFR TKI only a minor proportion of patients with NSCLC have genetically profiled biopsies. Guidelines provide evidence to perform EGFR and KRAS mutation analysis in non-squamous NSCLC. We explored tumo